CSL vs IEX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CSL exhibits a stable but mediocre Piotroski F-Score of 4/9, indicating a lack of strong financial momentum. The stock is trading at a massive premium, with a current price of $360.07 far exceeding both the Graham Number ($130.25) and the Intrinsic Value ($120.26). This valuation gap is exacerbated by stagnant revenue growth (0.40%) and sharply declining earnings growth (-14.60% YoY). Despite strong ROE and liquidity, the combination of bearish insider selling by the CEO and CFO and a technical trend of 0/100 suggests significant downside risk.
IDEX Corporation presents a dichotomy between exceptional operational consistency and severe valuation premiums. While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, the stock is trading significantly above its Graham Number ($88.24) and Intrinsic Value ($97.75). The company boasts a remarkable earnings track record, beating estimates in 23 of the last 25 quarters, yet revenue and earnings growth remain sluggish at 4.2% and 5.5% respectively. Consequently, the current price of $207.39 represents a high-premium bet on quality over value.
Compare Another Pair
Related Comparisons
CSL vs IEX: Head-to-Head Comparison
This page compares Carlisle Companies Incorporated (CSL) and IDEX Corporation (IEX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.